American Association for Cancer Research (AACR)
Founded in 1907, the American Association for Cancer Research (AACR) is the world's first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR’s membership includes 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 17,000 attendees. In addition, the AACR publishes seven peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of individual and team science grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer.
For more information about the AACR, visit www.AACR.org.
Follow the AACR on Twitter: @aacr #aacr
Follow the AACR on Facebook: https://www.facebook.com/aacr.org
Feinstein Kean Healthcare (FKH) is a leading strategy and communications partner for emerging and established organizations whose innovations are helping to transform life sciences and healthcare. Our firm works with clients at the intersection where disruptive technologies and ideas influence medicine, clinical research and practice, business models, public policy, and public opinion and behaviors. For 25 years, FKH has been a trusted partner to leading healthcare, technology, biotechnology, informatics and patient advocacy organizations. Hundreds of clients have turned to FKH to develop and execute programs that drive product commercialization; forge partnerships; transform markets; build constituencies and help to shape policies. FKH established the first personalized medicine practice in the nation in 2004, and has worked with commercial, academic and government innovators to advance adoption of personalized medicine approaches ever since. For more information about FKH, visit www.fkhealth.com.
Personalized Medicine Coalition
The Personalized Medicine Coalition, representing scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. An education and advocacy organization launched in 2004 and numbering more than 220 institutions from around the world, PMC focuses exclusively on personalized medicine. By tailoring medical treatment to the individual characteristics of each patient so that preventive and therapeutic interventions can be concentrated on those who will benefit, sparing expense and side effects for those who will not, PMC envisions a more efficient healthcare system that improves care and increases value. For more information about PMC, visit www.personalizedmedicinecoalition.org and follow PMC on Twitter @newsfromPMC.